Dasatinib-Induced Nephrotic Syndrome: A Case Report

Second-generation tyrosine kinase inhibitors (TKI), such as nilotinib and dasatinib, are used in the first-line treatment of chronic myeloid leukemia (CML), usually after the failure or resistance to imatinib. Despite a good safety profile, medications in this category have an increased incidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: ElShaer, Ahmed, Almasry, Mazen, Alawar, Maher, Masoud, Hassan, El Kinge, Abdul Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665416/
https://www.ncbi.nlm.nih.gov/pubmed/34912656
http://dx.doi.org/10.7759/cureus.20330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665416/
https://www.ncbi.nlm.nih.gov/pubmed/34912656
http://dx.doi.org/10.7759/cureus.20330

Ejemplares similares